CD44 and central nervous system cancer: The observed difference in Cd44 expression among spheroids derived from different tumor strains is consistent with the notorious clinical and molecular heterogeneity of gliomas; the expression of CD44 is associated with age, chemotherapy, grade, and primary/recurrent/secondary tumor type of gliomas in humans [32].